Category : Digestive Health

Genes alone cannot explain the current rise in colorectal cancer (CRC) and scientists are now trying to elucidate the gut microbiota's contribution as an important player. Previous human research has shown mechanisms by which the bacteria might affect tumorigenesis, especially in the early stages. However, gut microbiome signatures of CRC in association studies have not always been validated across different…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Genes alone cannot explain the current rise in colorectal cancer (CRC) and scientists are now trying to elucidate the gut microbiota's contribution as an important player. Previous human research has shown mechanisms by which the bacteria might affect tumorigenesis, especially in the early stages. However, gut microbiome signatures of CRC in association studies have not always been validated across different…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Although the underlying mechanisms involved in inflammatory bowel disease (IBD) pathogenesis remain elusive, it is known that certain genes, which are shared by both Crohn’s disease (CD) and ulcerative colitis (UC) patients, may show a predisposition to the development of this disease. Furthermore, the intestinal bacterial and fungal microbiota might also drive disease pathogenesis and progression. Despite this knowledge, the…

GMFH Editing Team
GMFH Editing Team

Although the underlying mechanisms involved in inflammatory bowel disease (IBD) pathogenesis remain elusive, it is known that certain genes, which are shared by both Crohn’s disease (CD) and ulcerative colitis (UC) patients, may show a predisposition to the development of this disease. Furthermore, the intestinal bacterial and fungal microbiota might also drive disease pathogenesis and progression. Despite this knowledge, the…

GMFH Editing Team
GMFH Editing Team

Celiac disease is a common food sensitivity triggered by gluten and its incidence is rising at an alarming rate. The reasons for this are not fully understood but suggestions are that they relate to changes in gut microbial composition or function. As part of previous research into gluten digestion processes, Dr. Alberto Caminero of  McMaster University (Canada) had described a…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Celiac disease is a common food sensitivity triggered by gluten and its incidence is rising at an alarming rate. The reasons for this are not fully understood but suggestions are that they relate to changes in gut microbial composition or function. As part of previous research into gluten digestion processes, Dr. Alberto Caminero of  McMaster University (Canada) had described a…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

The existing evidence about a different gut microbiota composition between healthy and obese or type 2 diabetic patients has led scientists to study the role of gut microbes in the onset and development of metabolic diseases. Several mechanisms by which the gut microbiota may interfere with energy metabolism are currently being explored, though it is not fully understood how the…

GMFH Editing Team
GMFH Editing Team

The existing evidence about a different gut microbiota composition between healthy and obese or type 2 diabetic patients has led scientists to study the role of gut microbes in the onset and development of metabolic diseases. Several mechanisms by which the gut microbiota may interfere with energy metabolism are currently being explored, though it is not fully understood how the…

GMFH Editing Team
GMFH Editing Team

One of the important roles played by the gut microbiota involves directing maturation of the mammalian immune system, although the molecular basis involved is still being characterized. As a result, the intimate relationships between commensal microorganisms and the host system are subject to an increasing amount of research into managing immune-related conditions. In particular, the induction of intestinal CD8 T…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

One of the important roles played by the gut microbiota involves directing maturation of the mammalian immune system, although the molecular basis involved is still being characterized. As a result, the intimate relationships between commensal microorganisms and the host system are subject to an increasing amount of research into managing immune-related conditions. In particular, the induction of intestinal CD8 T…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Microbiota for Health is pleased to present its “Year at a Glance 2018” document! This new report is led by an editorial from Prof. Stéphane Schneider, Head of the Nutritional Support Unit in the Gastroenterology and Nutrition Department at Archet University Hospital in Nice (France), and summarizes the relevant advances in gut microbiota science in 2018. The last year…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health is pleased to present its “Year at a Glance 2018” document! This new report is led by an editorial from Prof. Stéphane Schneider, Head of the Nutritional Support Unit in the Gastroenterology and Nutrition Department at Archet University Hospital in Nice (France), and summarizes the relevant advances in gut microbiota science in 2018. The last year…

GMFH Editing Team
GMFH Editing Team

The use of complementary alternative medicine (CAM) is common among patients living with inflammatory bowel disease (IBD). For the purpose of this article, CAM is defined as therapies that go beyond traditional pharmacological approaches. Patients turn to CAM for many reasons, but most commonly the patient is either unhappy with their current treatment or is looking for a more holistic…

Natasha Haskey
Natasha Haskey is a Registered Dietitian and PhD student at The Centre for Microbiome and Inflammatory Research at the University of British Columbia – Okanagan (Kelowna, British Columbia, Canada). Her research work focuses on how dietary factors influence the gut microbiome, immune system and clinical disease in inflammatory bowel diseases. She is the co-author of the textbook Gut Microbiota: Interactive Effects on Nutrition and Health, which focuses on the gut microbiome as it relates to nutrition. Follow Natasha on Twitter @nhaskeyRD

The use of complementary alternative medicine (CAM) is common among patients living with inflammatory bowel disease (IBD). For the purpose of this article, CAM is defined as therapies that go beyond traditional pharmacological approaches. Patients turn to CAM for many reasons, but most commonly the patient is either unhappy with their current treatment or is looking for a more holistic…

Natasha Haskey
Natasha Haskey is a Registered Dietitian and PhD student at The Centre for Microbiome and Inflammatory Research at the University of British Columbia – Okanagan (Kelowna, British Columbia, Canada). Her research work focuses on how dietary factors influence the gut microbiome, immune system and clinical disease in inflammatory bowel diseases. She is the co-author of the textbook Gut Microbiota: Interactive Effects on Nutrition and Health, which focuses on the gut microbiome as it relates to nutrition. Follow Natasha on Twitter @nhaskeyRD

Recent research has involved genetics, altered mucosal immune responses, environmental factors and the gut microbiome as major players in the development of inflammatory bowel disease (IBD). Given that some patients do not respond to conventional treatments, scientists are currently exploring new gut microbiome-targeted therapeutic approaches to improve disease course. A new study, led by Dr. Ramnik Joseph Xavier from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has involved genetics, altered mucosal immune responses, environmental factors and the gut microbiome as major players in the development of inflammatory bowel disease (IBD). Given that some patients do not respond to conventional treatments, scientists are currently exploring new gut microbiome-targeted therapeutic approaches to improve disease course. A new study, led by Dr. Ramnik Joseph Xavier from the…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).

Traditionally, the diet low in fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) - best as a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible carbohydrates (i.e., FODMAPs) followed by reintroduction of some of them according to tolerance - has been widely used for overall gastrointestinal symptom relief in patients with irritable bowel syndrome (IBS). However, decreasing…

Andrea Hardy
Registered Dietitian, Andrea Hardy from Calgary, Canada specializes in gastrointestinal disorders and the gut microbiome. She is recognized as Canada’s gut health dietitian – educating health care professionals and the public on the pivotal role nutrition plays in gut health. You can find her at Ignite Nutrition, or on Twitter (@AndreaHardyRD).